Exploratory Literature Meta-Analysis to Characterize the Relationship Between Early and Longer Term Body Weight Loss for Antiobesity Compounds-Reference-Cited by-同舟云学术

Exploratory Literature Meta-Analysis to Characterize the Relationship Between Early and Longer Term Body Weight Loss for Antiobesity Compounds

Published:2016-07-07 Issue:1 Volume:57 Page:52-63
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Plock Nele¹,Bax Leon²,Lee Douglas³,DeManno Deborah⁴,Lahu Gezim¹,Pfister Marc²⁵

Affiliation:

1. Takeda Pharmaceuticals International AG; Zürich Switzerland

2. Quantitative Solutions a Certara Company; Menlo Park CA USA

3. Takeda Development Centre Europe Ltd; London UK

4. Takeda Pharmaceuticals International, Inc; Deerfield IL USA

5. University of Basel; Basel Switzerland

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference116 articles.

1. World Health Organization http://www.who.int/mediacentre/factsheets/fs311/en/

2. Anti-obesity drugs: past, present and future;Rodgers;Dis Model Mech,2012

3. Qsymia Prescribing Information VIVUS, Inc., Mountain View, CA, USA https://qsymia.com/pdf/prescribing-information.pdf

4. Belviq Prescribing Information Arena Pharmaceuticals GmbH, Zofingen, Switzerland http://www.belviq.com/documents/Belviq_Prescribing_information.pdf

5. U.S. Food and Drug Administration http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM312391.pdf

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dyskalemia risk associated with fixed-dose anti-hypertensive medication combinations;Journal of Human Hypertension;2021-09-23

2. Model‐Based Meta‐Analysis: Optimizing Research, Development, and Utilization of Therapeutics Using the Totality of Evidence;Clinical Pharmacology & Therapeutics;2019-06-14

3. Translational Modeling to Guide Study Design and Dose Choice in Obesity Exemplified by AZD1979, a Melanin-concentrating Hormone Receptor 1 Antagonist;CPT: Pharmacometrics & Systems Pharmacology;2017-05-27

4. Medical Management of Diabesity: Do We Have Realistic Targets?;Current Diabetes Reports;2017-01